FDC Ltd
Next 500 2024
+ 9 More
+ 9 More
Share
Share
OVERVIEW
FINANCIALS
About
FDC Limited is a pharmaceutical company specializing in oral rehydration salts (ORS), ophthalmic solutions, and anti-infectives. With a strong research and development focus, the company has pioneered several formulations, including India’s first ORS powder. Its diverse portfolio includes medicines for gastroenterology, dermatology, respiratory care, and cardiology. FDC has a significant presence in both domestic and international markets, exporting to over 50 countries. Committed to innovation and quality, the company operates multiple manufacturing facilities that adhere to global regulatory standards. Through its healthcare initiatives, FDC continues to contribute to medical advancements and improved patient outcomes.
Incorporation Year: 1940
Headquarters: Mumbai, Maharashtra, India
Top Management: Anand Chandavarkar (CEO)
Industry: Pharma
Website: fdcindia.com
Featured In Fortune India Ranking
Next 500 India
#301(2024)#182(2023)#114(2022)#113(2021)#248(2020)#211(2019)#259(2018)#249(2017)#268(2016)#374(2015)
#301(2024)#182(2023)#114(2022)#113(2021)#248(2020)#211(2019)#259(2018)#249(2017)#268(2016)#374(2015)
Ranking Trend Fortune Next 500 India
Financial Data 2024
Revenue
2,098
(INR Cr)
Net Operating Income
1,943
(INR Cr)
Assets
2,148
(INR Cr)
Profit
305
(INR Cr)
Net Worth
2,097
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 2098 13.5% | 1849 10.7% | 1669 14.6% | 1456 3.4% | 1408 21.8% | 1156 2.5% | 1129 5.8% | 1067 2.7% | 1038 10.2% | 942 6.1% | 888 9.4% | 812 8.4% | 749 1.4% | 739 12.1% | 659 9.1% | 604 - |
| Net Operating Income (INR Cr) | 1943 8.92% | 1784 16.74% | 1528 14.61% | 1333 -0.82% | 1344 23.24% | 1091 1.45% | 1075 6.04% | 1014 1.97% | 994 11.81% | 889 5.14% | 846 9.45% | 773 8.77% | 711 -0.16% | 712 12.58% | 632 7.27% | 589 19.03% |
| Profit (INR Cr) | 305 57.3% | 194 -10.3% | 216 -28.2% | 301 25.6% | 240 41.3% | 170 -2.1% | 174 -8.0% | 189 11.8% | 169 13.9% | 148 9.5% | 135 -12.8% | 155 15.7% | 134 -11.1% | 151 1.2% | 149 73.0% | 86 - |
| Assets (INR Cr) | 2148 5.9% | 2028 2.0% | 1989 13.7% | 1749 11.9% | 1563 8.0% | 1448 13.2% | 1279 0.6% | 1271 17.3% | 1084 15.4% | 939 10.7% | 848 7.7% | 787 12.6% | 699 12.3% | 623 17.2% | 532 23.8% | 429 - |
| Net Worth (INR Cr) | 2097 5.8% | 1982 1.3% | 1957 12.8% | 1734 12.1% | 1547 7.1% | 1445 13.3% | 1276 0.5% | 1270 17.3% | 1082 15.7% | 936 10.8% | 845 7.8% | 784 12.8% | 695 12.9% | 616 17.1% | 526 24.6% | 422 13.0% |
| Employee Cost (INR Cr) | 413 5.8% | 391 13.9% | 343 15.9% | 296 6.8% | 277 23.0% | 226 4.1% | 217 13.4% | 191 8.7% | 176 27.8% | 138 12.7% | 122 13.5% | 108 8.6% | 99 15.7% | 86 18.2% | 72 23.3% | 59 - |
| Interest Cost (INR Cr) | 4 | 4 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 1 | 1 | 2 |
| Cash & Bank Balance (INR Cr) | 26 | 25 | 39 | 32 | 32 | 21 | 29 | 28 | 18 | 15 | 23 | 37 | 17 | 18 | 17 | 13 |
| Total Debt (INR Cr) | 21 | 28 | 32 | 15 | 15 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | 7 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 14.6% | 10.5% | 13.0% | 20.7% | 17.0% | 14.7% | 15.4% | 17.7% | 16.2% | 15.7% | 15.2% | 19.1% | 17.9% | 20.4% | 22.6% | 14.3% |
| Profit As % Of Assets | 14.2% | 9.6% | 10.9% | 17.2% | 15.4% | 11.7% | 13.6% | 14.8% | 15.6% | 15.8% | 16.0% | 19.7% | 19.2% | 24.2% | 28.1% | 20.1% |
| Profit As % Of Networth | 14.6% | 9.8% | 11.1% | 17.4% | 15.5% | 11.8% | 13.6% | 14.8% | 15.6% | 15.8% | 16.0% | 19.8% | 19.3% | 24.5% | 28.4% | 20.4% |
| Interest Cost to EBITDA % | 1.2% | 1.6% | 1.2% | 1.0% | 1.2% | 0.6% | 0.6% | 0.6% | 0.6% | 0.9% | 1.5% | 0.9% | 0.9% | 0.9% | 0.9% | 1.6% |
| Debt to Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| RONW | 15.0% | 9.8% | 11.7% | 18.4% | 16.0% | 12.5% | 13.6% | 16.0% | 16.7% | 16.6% | 16.6% | 18.3% | 20.5% | 26.4% | 31.5% | 21.7% |
| ROCE | 19.2% | 13.0% | 15.7% | 23.6% | 21.5% | 17.5% | 19.0% | 21.5% | 23.1% | 23.0% | 27.1% | 23.4% | 26.3% | 30.7% | 38.0% | 26.9% |